semaglutide aging A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% 💉 Ozempic may be doing

One aspect in the clinical management of POTS patients that merits discussion is the worsening pre-syncopal symptoms and tachycardia, particularly after high-carbohydrate meals

Check the prescribing information for your specific medication and talk with your healthcare provider

While this might seem cheaper, its also risky: No physician monitoring means no dosage adjustments or safety oversight No nutritional guidance means less optimal results No accountability means higher dropout rates Youre on your own if you experience side effects or complications The difference between $250/month DIY and $275-$333/month for comprehensive physician-supervised care is minimaland the outcomes are vastly different

Many people who take GLP-1 drugs to treat obesity or diabetes discontinue them

Directly activating PKA and EPAC raises cAMP quickly